Índice

• • ·Title

    Página :i

    
• • ·Author Index

    Página :e1

    
• • ·CSANZ NZ Abstracts

    Página :e3

    
• • ·The impact of body mass index on mortality and cardiovascular events following acute coronary syndrome: Is there an obesity paradox?

    Página :e3

    J. Sathananthan, M. Lee, A. Kerr

    
• • ·Prasugrel inhibits platelet stimulation of pro-inflammatory T cells in humans

    Página :e3

    L. Johnston, A. La Flamme, P. Larsen, S. Harding

    
• • ·Stimulation of platelet toll-like receptors results in marked platelet activation that is partially inhibited by prasugrel but not aspirin

    Página :e4

    M. Bass, M. Chen-Xu, A. Sasse, A. La Flamme, P. Larsen, S. Harding

    
• • ·Novel ECG derived risk markers in implantable cardioverter defibrillator (ICD) patients

    Página :e4

    B. Shi, S. Harding, P. Larsen

    
• • ·Nurse led chest pain clinics: The south Auckland experience

    Página :e4

    C. Aldridge, A. McLachlan, S. Wong, A. Kerr, K. McLean

    
• • ·Supporting the achievement of Ministry of Health (MOH) cardiovascular disease (CVD) targets through an Inpatient CVD screening program in South Auckland

    Página :e5

    R. Swindells, C. Narbey, A. Alexander, A. Kerr, Y. Moh, A. McLachlan

    
• • ·Patient experience survey: Total ambulatory management and coronary angiography day stay procedures

    Página :e5

    S. Savage, T. Gudex, M. McAleer, P. Ruygrok, S. Madenholt-Titley, J. White

    
• • ·Same day discharge (SDD) for pecutaneous coronary intervention (PCI): A safe, effective, resource responsible strategy to improve the patient journey

    Página :e5

    J. Besley, S. Wilson

    
• • ·Slow for the amber or give it heaps? Traffic lights to prevent contrast induced nephropathy

    Página :e6

    R. Newcombe, G. Armstrong, A. Cave, C. Inocentes, S. El Jack, A. Khan

    
• • ·Factors contributing to failure to achieve a 10J safety margin in implantable cardioverter defibrillator testing

    Página :e6

    K. Singh, B. Shi, S. Bloomfield, G. Furniss, A. Jimenez, S. Harding, P. Larsen

    
• • ·Management and long-term outcome in heart failure (HF) associated with acute coronary syndrome (ACS) in a contemporary New Zealand cohort

    Página :e6

    A. Kueh, M. Lee, G. Devlin, A. Kerr

    
• • ·Paramedic initiated helivac to tertiary hospital for primary percutaneous coronary intervention: Initial experience and outcomes

    Página :e7

    P. Davis, P. Ruygrok, R. Howard, G. Howie

    
• • ·How many dialysis patients receive transplantation after achieving eligibility by undergoing coronary artery bypass grafting?

    Página :e7

    J. Sathananthan, H. Pilmore, J. De Zoysa, P. Ruygrok

    
• • ·Resumption of platelet function by verify-now assay after cessation of ticagelor in acute coronary syndrome patients awaiting surgical revascularisation

    Página :e8

    M. Lee, V. Pera, K. Sree Raman, G. Devlin, A. El-Gamel

     
• • ·Management of non ST-elevation acute coronary syndrome (NSTEACS) patients in New Zealand (NZ): A longitudinal analysis. Results from the NZACS national audits of 2002, 2007 and 2012

    Página :e8

    G. Devlin, A. Hamer, R. Throughton, G. Gamble, P. Matsis, M. Williams, J. Elliott, S. Mann, A. Richards, J. French, H. White, C. Ellis, for the NZ Regional Cardiac Society ACS Audit Group and the CSANZ ‘SNAPSHOT’ ACS Audit Group

    
• • ·A comparison of discharge medications and rehabilitation services available for acute coronary syndrome (ACS) patients in Australia and New Zealand: Results of the 2012 SNAPSHOT Bi-National audit

    Página :e9

    C. Ellis, T. Briffa, C. Hammet, J. French, J. Lefkovits, I. Ranasinghe, G. Devlin, J. Elliott, F. Turnbull, J. Redfern, B. Aliprandi-Costa, C. Astley, G. Gamble, D. Brieger, D. Chew, for the Bi-National Acute Coronary Syndromes (ACS) ‘SNAPSHOT’ Audit Group

    
• • ·Exposure to parental smoking in childhood is associated with increased risk of carotid atherosclerotic plaque in adults

    Página :e9

    H. West, C. Magnussen, M. Juonala, M. Kähönen, T. Laitinen, L. Taittonen, J. Viikari, O. Raitakari

    
• • ·Should indexation of left ventricular volume be sex and ethnic specific? A report from the EchoNoRMAL meta-analysis

    Página :e10

    K. Poppe, C. Triggs, I. Squire, I. Simova, A. Ng, L. Thomas, R. Hobbs, H. Dalen, R. Izzo, G. de Simone, G. Whalley, E. Rietzschel

    
• • ·Evaluation of cardiac axis changes related to obesity and aging by surface electrocardiogram and cardiac computed tomography

    Página :e10

    G. Sathananthan, W. Chik, S. Zahid, G. Aggarwal, D. Friedman, A. Thiagalingam

    
• • ·Diagnostic accuracy of different electrocardiographic and radiographic criteria for left atrial enlargement as assessed by cardiac magnetic resonance

    Página :e10

    S. Pumprueg, T. Boonyasirinant, S. Boorakham

    
• • ·Early outcome of transcatheter aortic-valve implantation in high risk patients: The Auckland experience from 2011 to 2014

    Página :e11

    S. Wu, J. Stewart, M. Webster, J. White

    
• • ·Pre-operative atrial fibrillation is independently associated with short and long-term mortality after aortic valve replacement

    Página :e11

    T. Wang, D. Choi, T. Ramanathan, P. Ruygrok

    
• • ·The prognostic value of T peak - T end interval on the surface ECG in patients undergoing reperfusion therapy for STEMI

    Página :e12

    B. John, S. Dey, J. Jacob, V. Raghavan

    
• • ·Cardiac sarcoidosis: The Christchurch experience

    Página :e12

    I. Melton, P.O. Adamson, J. Donnell, S. MacDonald, I. Crozier

    
• • ·The development and implementation of a real time, cardiac rehabilitation tracking system

    Página :e12

    A. McLachlan, K. McLean, S. Breen, A. Kerr

    
• • ·Polypills for high risk patients: Results of a New Zealand randomised controlled trial

    Página :e13

    V. Selak, C. Elley, S. Crengle, A. Wadham, N. Rafter, C. Bullen

    
• • ·The effects of ticagrelor on platelet reactivity and short term outcomes in acute coronary syndromes

    Página :e13

    A. Al-Sinan, P. Matsis, M. Simmonds, L. Johnston, P. Larsen, S. Harding

    
• • ·The fate of 302 patients receiving consecutive bio-prosthetic aortic valve replacements

    Página :e13

    M. Haydock, C. Wilkes, T. Ramanathan, D. Haydock

    
• • ·Comparison of four contemporary risk scores for predicting mortality and morbidity after aortic valve replacement

    Página :e14

    T. Wang, R. Stewart, D. Choi, G. Gamble, D. Haydock, P. Ruygrok

    
• • ·Acute coronary syndromes in patients with prior MI: Secondary prevention and outcomes

    Página :e14

    S. Fairley, S. Harding, M. Liang, A. Aitken, A. Ranchord, P. Larsen

    
• • ·Prevalence and predictors of right ventricular dysfunction in patients with left ventricular systolic dysfunction: Insights from cardiac magnetic resonance

    Página :e15

    T. Boonyasirinant, C. Charunwikan, R. Krittiyaphong

    
• • ·Radiation dose and positive predictive value of revascularisation with low dose myocardial perfusion scintigraphy compared with computed tomography coronary angiography

    Página :e15

    I. Subiakto, A. Ul Haq, A. Vlachadis Castles, W. Van Gaal

    
• • ·Temporary and permanent discontinuation of clopidogrel following acute coronary syndromes

    Página :e15

    D. Middleditch, B. Scott, M. Simmonds, A. Aitken, L. Johnston, P. Larsen, S. Harding

    
• • ·The effect of programming on therapy rates in implantable cardioverter defibrillator patients

    Página :e16

    S. Levings, M. Stiles, S. Heald, A. Jimenez, B. Shi, S. Harding, P. Larsen

    
• • ·The effect of cardiac surgery on the Q-T interval. Are patients at higher risk of torsades de pointes post cardiac surgery?

    Página :e16

    T. Pasley, M. Gillham

    
• • ·The left ventricular response todobutamine in patients after Apical Ballooning Syndrome compared to male and female controls

    Página :e17

    G. Sathananthan, J. Looi, A. Kerr

    
• • ·Clothing optional reducing patient anxiety during coronary angiography

    Página :e17

    H. Abernethy, J. Besley, S. Wilson

    
• • ·Early repeat transradial access for coronary angiography and percutaneous coronary intervention

    Página :e17

    E. Aiken, J. Money, B. Kneale

    
• • ·4F angiography is associated with less contrast usage, shorter procedure time and earlier discharge with preserved diagnostic utility - a comparison with 5F angiography

    Página :e18

    S. Prabhu, M. Freilich, N. Lonergan, M. Nguyen, N. Fishlock, C. Wimalagunasekera, N. Muir, D. Saleh, M. Arrowsmith, J. Layland

    
• • ·Cryoballoon ablation for atrial fibrillation

    Página :e18

    M. Arshad, M. Daly, I. Crozier, I. Melton

    
• • ·Second generation cryoballoons - are they any better?

    Página :e19

    M. Arshad, M. Daly, I. Crozier, I. Melton

    
• • ·Sever aortic stenosis-prevalence and management experience from the Bay of Plenty

    Página :e19

    M. Arshad, G. Porter

    
• • ·Acute coronary syndrome with non obstructive coronary angiography; Rates, treatment, and outcomes at Middlemore Hospital

    Página :e19

    P. Barr, A. Kerr

    
• • ·New Zealand's ‘approach’ to coronary angiography: A descriptive analysis of arterial access for invasive coronary angiography

    Página :e20

    P. Barr, C. Flynn, D. Smyth, A. Kerr

    
• • ·Cost effectiveness of transcatheter aortic valve implantation (TAVI) for patients with severe symptomatic aortic stenosis in New Zealand

    Página :e20

    S. Bhattacharyya, M. Roskruge, S. Haynes, T. Ramanathan, M. Webster, P. Ruygrok

    
• • ·Spatial QRS-T angle following acute coronary syndromes

    Página :e20

    S. Blomfield, B. Shi, S. Harding, P. Larsen

    
• • ·The cardiac sonographer workforce in NZ - Results from the 2013 SCANZ workforce survey

    Página :e21

    B. Buckley, M. Farnworth, S. White, G. Whalley

    
• • ·Post code lottery exists in echocardiography provision in New Zealand

    Página :e21

    B. Buckley, K. Poppe, M. Farnworth, G. Whalley

    
• • ·Is myocardial B1- and B2-adrenoceptor responsiveness altered in conscious Zucker Diabetic Fatty rats?

    Página :e21

    R. Cook, C. Bussey, P. Cragg, R. Lamberts

    
• • ·Electrophysiology assessment and radiofrequency ablation of arrhythmias in adult patients with congenital heart defects: The Christchurch experience

    Página :e22

    M. Daly, K. Frankish, J. Greenslade, S. Denekamp, J. Lainchbury, I. Melton, D. Hooks, I. Crozier

    
• • ·Implementation of a high sensitivity troponin assay reduces time spent in the emergency department by patients with a possible acute coronary syndrome

    Página :e22

    A. Early, R. Cooke, M. Nguyen, S. Mann

    
• • ·A decade of improvement in investigations received and treatments delivered to New Zealand (NZ) ST-elevation myocardial infarction (STEMI) patients: Results from the NZACS national audits of 2002, 2007 and 2012

    Página :e22

    J. Elliott, M. Williams, P. Matsis, G. Gamble, R. Troughton, A. Hamer, G. Devlin, S. Mann, A. Richards, J. French, H. White, C. Ellis, for the NZ Regional Cardiac Society ACS Audit Group and the CSANZ ‘SNAPSHOT’ ACS Audit Group

    
• • ·A comparison of invasive angiography, revascularisation and time delays delivered to Australian and New Zealand non-ST-elevation myocardial infarction/unstable angina pectoris (NSTEMI/UAP) patients: results of the 2012 SNAPSHOT Bi-National acute coronary Syndrome (ACS) audit

    Página :e23

    C. Ellis, C. Hammett, J. French, T. Briffa, J. Lefkovitz, I. Ranasinghe, G. Devlin, J. Elliott, F. Turbull, J. Redfern, B. Aliprandi-Costa, C. Astley, G. Gamble, D. Brieger, D. Chew, for the Bi-National Acute Coronary Syndromes (ACS) ‘SNAPSHOT’ Audit Group

     
• • ·Improved rates of secondary prevention medication following hospitalisation for an acute coronary syndrome (ACS) in New Zealand (NZ): Results from the NZ ACS national audits of 2002, 2007 and 2012

    Página :e23

    C. Ellis, G. Gamble, G. Devlin, J. Elliott, A. Hamer, P. Matsis, M. Williams, R. Troughton, S. Mann, J. French, A. Richards, H. White, for the NZ Regional Cardiac Society ACS Audit Group and the CSANZ ‘SNAPSHOT’ ACS Audit Group

    
• • ·Diabetes causes the activation of the pro-ageing miRNA-34a in the human heart

    Página :e24

    I. Fomison-Nurse, P. Saxena, S. Coffey, A. Menon, R. Bunton, I. Galvin, A. Bahn, M. Williams, V. Cameron, R. Katare

    
• • ·Stent length and GP2B/3A Inhibitor use but not eGFR predict peri-procedural myocardial infarction in elective percutaneous coronary intervention

    Página :e24

    C. Goh, A. Al-Fiadh, D. Clark, O. Farouque

    
• • ·Ticagrelor in the management of acute coronary syndromes

    Página :e25

    S. Green, T. Cherian, C. Heald, M. Lee, G. Devlin

    
• • ·Introduction and evaluation of total ambulatory management of patients undergoing coronary angiography and intervention

    Página :e25

    T. Gudex, S. Madenholt-Titley, M. McAleer, S. Savage, J. White, P. Ruygrok

    
• • ·Platelet count and platelet function testing in acute coronary syndromes

    Página :e26

    K. Hally, L. Johnston, A. Holley, P. Larsen, S. Harding

    
• • ·Low prevalence of left atrial thrombus detected by transoesphageal echocardiogram in patients with arrhythmia prior to DC cardioversion

    Página :e26

    D. Hare, A. Pope, S. Kueh, J. Looi, N. van Pelt, R. Gabriel

    
• • ·Characteristics, outcomes, and complications during the first year of coronary rotational atherectomy at Middlemore Hospital

    Página :e26

    W. Harrison, R. McIntosh, S. Graham, C. Flynn, A. Escondo, P. Kay

    
• • ·Short to medium term outcome of Bioresorbable Scaffolds for treatment of coronary stenosis: The Christchurch experience

    Página :e27

    T. Hii, D. McClean, A. Puri, J. Blake, J. Elliott, D. Smyth

    
• • ·Variability and prognostic significance of antioxidant enzymes in acute coronary syndromes (ACS)

    Página :e27

    A. Holley, J. Miller, S. Harding, P. Larsen

    
• • ·Effects of pre-hospital ECG transmission for ST-elevation myocardial infarction in Counties Manukau

    Página :e27

    M. Jain, A. Loh, M. Lee, D. Hailstone, A. Kerr

    
• • ·Trastuzumab induced cardiotoxicity in Auckland

    Página :e28

    K. Johnson, J. Signy, J. Pemberton, J. Cadogan

    
• • ·Management of valvular heart disease: Role of echocardiography and assessment of pulmonary hypertension reversibility

    Página :e28

    K. Khokhar, G. Devlin, A. El-Gamel, R. Fisher, P. Jogia

    
• • ·Percutaneous coronary intervention (PCI) outcomes at Tauranga Hospital: A new non-surgical centre's early experience

    Página :e29

    B. Kneale, J. Money

    
• • ·Cryoablation for AF in the Waikato; Early results

    Página :e29

    E. Kooijman, I. Grey, R. Allen, S. Heald, D. Boddington, M. Stiles

    
• • ·Clinical characteristics and outcomes of patients with P-associated cardiomyopathy (PAC) in Auckland, New Zealand

    Página :e30

    A. Kueh, J. Bradley, T. Sutton, R. Gabriel, M. Lund, J. Looi

    
• • ·Long-term clinical outcome of patient with type I vs type II non-STEMI

    Página :e30

    A. Kueh, M. Lee, A. Kerr

    
• • ·Warfarin vs Dabigatran for elective direct current cardioversion (DCCV)

    Página :e30

    A. Kueh, D. Judson, K. Reed, R. Gabriel, J. Looi, D. Heaven, N. van Pelt

    
• • ·Does timing of platelet function testing (PFT) contribute to variability in residual on-treatment platelet reactivity in patients with acute coronary syndrome (ACS)?

    Página :e31

    C. Legge, A. Al-Sinan, A. Holley, L. Johnston, P. Larsen, S. Harding

    
• • ·This abstract has been withdrawn

    Página :e31

    
• • ·This abstract has been withdrawn

    Página :e31

    
• • ·Prevalence and predictors of subclinical coronary artery disease in patients with confirmed heterozygous familial hypercholesterolaemia

    Página :e31

    J. Lumby, A. Moffat, T. Bates, G. Watts, A. Abraham

    
• • ·Reduced sedation in patients undergoing coronary angiography of total ambulatory management

    Página :e32

    S. MadenHolt-Titley, T. Gudex, M. McAleer, S. Savage, J. White, P. Ruygrok

    
• • ·Audit of the burden of rheumatic heart disease in the Wellington region

    Página :e32

    M. Margetts, A. Aitken, N. Wilson

    
• • ·Transcatheter aortic valve implantation in patients with percutaneous coronary intervention to the left main coronary artery

    Página :e32

    A. Maurice, S. Chan, D. Murdoch, A. Clarke, D. Walters

    
• • ·The use of gastrointestinal cocktail for excluding myocardial ischaemia in the emergency setting: A systematic review

    Página :e33

    S. Chan, A. Maurice, S. Davies, D. Walters

    
• • ·Total ambulatory care (TAC) for day-stay coronary angiography patients (Amsterdam protocol): A positive response with suggested enhancements

    Página :e33

    M. McAleer, S. Madenholt-Titley, S. Savage, T. Gudex, J. White, P. Ruygrok

    
• • ·Interventional nursing perspective on seting up of a coronary rotational atherectomy service: First-year experiences and lessons learnt

    Página :e34

    R. McIntosh, S. Graham, W. Harrison, C. Flynn, A. Escondo, P. Kay

    
• • ·Are guidelines adhered to at first assessment of atrial fibrillation

    Página :e34

    I. Melton, L. Lim

    
• • ·Regional transfer; How much do patients know?

    Página :e34

    C. Mercier, G. Aldrich

    
• • ·Pathological autophagy augments cell death in the diabetic heart

    Página :e35

    E. Munasinghe, I. Fomison-Nurse, G. Hughes, P. Saxena, R. Bunton, I. Galvin, R. Katare

    
• • ·Outcomes of structural interventions in a hospital without onsite cardiothoracic surgery

    Página :e35

    R. Parameswaran, S. Koneru, R. Miller, G. Koshy, B. Herman

    
• • ·Fulminant myocarditis

    Página :e35

    K. Park, J. Beca, A. McKee, A. McGeorge, C. Wasywich, P. Ruygrok, N. Kingston, A. Coverdale

    
• • ·“Murmur clinic” - A novel use of cardiology resources to address an unmet need

    Página :e36

    T. Pasley, G. Porter

    
• • ·An audit of EP procedures and complications

    Página :e36

    T. Pasley, D. Boddington, S. Buttle

    
• • ·“Normal” coronary arteries in the setting of acute coronary syndrome: Frequency and outcomes

    Página :e36

    S. Plunkett, A. Ranchord, P. Matsis, A. Holley, P. Larsen, S. Harding

    
• • ·The development of a structured and cohesive service for people admitted to hospital with a diagnosis of heart failure. The 20,000 days campaign

    Página :e37

    J. Poole, A. McLachlan, L. Morley, S. Mooney, T. Sutton, A. Howitt, K. McLean, M. Lund

    
• • ·Can significant coronary artery disease be ruled out by CT coronary angiography in patients weighing greater than 100 kg?

    Página :e37

    A. Pope, A. Fyfe, R. Gabriel, J. Looi, D. Burt, S. Barnard, S. Tang, P. Weeks, F. Wu, N. van Pelt

    
• • ·CT coronary angiography can safely exclude significant coronary artery disease in patients undergoing valve and aorta surgery

    Página :e38

    A. Pope, A. Fyfe, R. Gabriel, J. Looi, S. Barnard, S. Tang, P. Weeks, F. Wu, N. van Pelt

    
• • ·Five year outcomes following pericardiocentesis in Middlemore Hospital patients

    Página :e38

    A. Pope, A. Jebb, T. Sutton

    
• • ·Circulating cardiovascular microRNAs as diagnostic biomarkers for early diagnosis of diabetic heart disease

    Página :e38

    S. Rawal, J. Paulin, E. Munasinghe, P. Manning, R. Katare

    
• • ·Novel approach to improving cardiac rehabilitation for all: The whanau ora way

    Página :e39

    L. Sami, S. Christophers, A. Kerr, A. Mclachan

    
• • ·Percutaneous coronary intervention rates and outcomes of coronary angiography in patients with prior CABG - an ANZACS-QI single centre study

    Página :e39

    G. Sathananthan, C. Flynn, D. Scott, P. Kay, W. Harrison, A. Kerr

    
• • ·This abstract has been withdrawn

    Página :e39

    
• • ·TAVI in New Zealand; A cost effective treatment for patients with aortic stenosis at high surgical risk?

    Página :e39

    D. Smyth, J. Blake, R. Troughton, M. Hart, G. Roper, D. Williams, H. Singh

    
• • ·Balloon aortic valvuloplasty (BAV) for the management of severe aortic stenosis in the era of transcatheter aortic valve implantation (TAVI)

    Página :e40

    K. Sree Raman, R. Nair, G. Devlin, S. Pasupati

    
• • ·How well are we doing in secondary prevention after myocardial infarction - The STABILITY study experience

    Página :e40

    R. Stewart, J. Benetar, A. Hamer, D. Scott, G. Devom, H. Hart, J. Elliott, J. Tisch, L. Davidson, M. Hills, N. Harrison, R. Rankin, T. O’Meeghan, V. Chen, H. White

    
• • ·Bleeding risk and incidence in real world percutaneous coronary intervention patients with ticagrelor

    Página :e41

    I. Subiakto, A. Ul Haq, W. Van Gaal

    
• • ·APACHE III score predicts mortality in out of hospital cardiac arrest (OOHCA) patients with ST elevation myocardial infarction (STEMI)

    Página :e41

    C. Tie, T. Kuang, J. Loubser, C. Frampton, D. Knight, D. Smyth

    
• • ·APACHE III score predicts mortality in out of hospital cardiac arrest (OOHCA) patients with non-ST elevation myocardial infarction (NSTEMI)

    Página :e42

    C. Tie, T. Kuang, J. Loubser, C. Frampton, D. Knight, D. Smyth

    
• • ·Prevalence of obstructive coronary artery disease among patients undergoing coronary angiography at an Australian Tertiary Hospital

    Página :e42

    D. Tsang, M. Yudi, S. Joshi

    
• • ·The Australian experience of government subsidisation of novel oral anticoagulants (NOACs)

    Página :e42

    A. Vlachadis Castles, W. van Gaal

     
• • ·AV junction ablation audit - Auckland City Hospital

    Página :e43

    J. Voss, L. Maher, C. Jones, N. Lever

    
• • ·Cardioplegia in contemporary coronary artery bypass grafting: Effects on high-sensitivity troponins and outcomes

    Página :e43

    T. Wang, A. Li, T. Wilcox, H. White, T. Ramanathan

    
• • ·Comparison of society of thoracic surgeon's risk models with EuroSCORE and EuroSCORE II at adverse outcome prediction after coronary artery bypass grafting

    Página :e44

    T. Wang, A. Li, T. Ramanathan, G. Gamble, R. Stewart, H. White

    
• • ·Diagnosis of myocardial infarction after aortic valve replacement with high-sensitivity troponins

    Página :e44

    T. Wang, R. Stewart, T. Ramanathan, D. Choi, G. Gamble, P. Ruygrok, H. White

    
• • ·Disparities of outcomes between Pacific Island and European patients undergoing coronary artery bypass grafting

    Página :e44

    T. Wang, R. Stewart, T. Ramanathan, G. Gamble, H. White

    
• • ·Elevation of aspartate aminotransferase predicts mortality after coronary artery bypass grafting

    Página :e45

    T. Wang, R. Stewart, T. Ramanathan, G. Gamble, H. White

    
• • ·Features and outcomes of eosinophilic myocarditis: A single-centre case series

    Página :e45

    T. Wang, T. Watson, B. Lowe, J. Pemberton, N. Kingston, C. Ellis, P. Ruygrok

    
• • ·Influence of cardioplegia techniques on outcomes after aortic valve replacement

    Página :e46

    T. Wang, D. Choi, T. Wilcox, H. White, T. Ramanathan

    
• • ·Relationships between anticoagulation regimen, risk score and adverse outcomes in dialysis patients with atrial fibrillation

    Página :e46

    T. Wang, J. Sathananthan, C. Hood, G. Gamble, M. Marshall, A. Kerr

    
• • ·Seven tear study of surgery for infective endocarditis: The contemporary Auckland City Hospital experience

    Página :e46

    T. Wang, T. Oh, J. Voss, N. Kang, J. Pemberton

    
• • ·Utility of pre-catheterisation high-sensitivity troponin T in patients without obstructive coronary artery disease

    Página :e47

    T. Wang, T. Oh, C. Samaranayake, T. Watson, J. Stewart, M. Webster, P. Ruygrok

    
• • ·Value of normal or mild coronary artery disease on angiography during workup of suspected angina pectoris

    Página :e47

    T. Wang, T. Oh, C. Samaranayake, T. Watson, J. Stewart, M. Webster, C. Ellis, P. Ruygrok

    
• • ·3D echo mitral valve reconstruction - validity of a novel software application

    Página :e48

    M. Wolbinski, A. Morgan, P. Larsen, A. Sasse

    
• • ·CT coronary angiography reporting in New Zealand. A survey of practitioners

    Página :e48

    C. Young